Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexavar in relapsed chronic lymphocytic leukemia
NCT00303966Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Nov 2005
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sorafenib in chronic lymphocytic leukemia (CLL), sponsored by National Cancer Institute. Started Nov 2005; status: terminated.
02
Drugs
sorafenib
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00303966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303966.